Category: Biotechnology
QIAGEN N.V., has recently announced that it has entered into a definitive agreement with N-of-One, Inc., the privately-held American molecular decision support company, which is renowned for innovating clinical …
A new breathalyzer test that is most likely to revolutionize the diagnosis of cancer will reportedly undergo clinical trials in Britain. As per credible sources, the breath test involves …
The firms will jointly develop preclinical molecule, MP0310 in combination with Amgen’s Oncology assets U.S. biopharmaceutical conglomerate, Amgen Inc. has recently announced a collaboration and license agreement with the …
Mobidiag, a Finnish-French biotechnology firm specializing in developing and marketing innovative solutions for molecular diagnostics of infectious diseases, has reportedly announced that it has entered into a joint venture (JV) …
The partnership will offer Innovent rights to develop and commercialize products in new markets. Renowned biopharmaceutical firm, Innovent Biologics and Incyte Corp. have recently entered into a strategic collaboration …
The Roche and Merck partnership is expected to expand the use of the biomarker panel for helping to select patients having solid tumors for immunotherapy The new diagnostic test …
The company raised $20 million through a series A funding round. Black Diamond also has another financing round in the works that would be announced at a later date. …
The collaboration would evaluate select drugs from both companies in combination with each other. In conjunction with the collaboration, Bristol-Myers would also make an equity investment in Vedanta. Bristol-Myers …
The licensing & collaboration agreement aims to discover treatments for neurological disorders. Roche would be responsible for any of the development & commercialization activities of the program. RocheHolding AG …
